PRJNA577155
IRIS RNAseq Data
We developed a versatile, big data-informed platform for discovering immunotherapy targets derived from Alternative Splicing events called IRIS (Isoform peptides from RNA splicing for Immunotherapy target Screening) and detected alternative splicing-derived tumor antigens from 23 glioblastoma patients from UCLA.